"Controversy Surrounding Xanax's Effectiveness"
A new study analyzing both published and unpublished clinical trial data has raised questions about the efficacy of alprazolam (Xanax XR), a widely prescribed benzodiazepine sedative. Out of the five FDA-reviewed trials, only one showed a clearly positive outcome. The study suggests that publication bias may have inflated the drug's effectiveness by over 40%. Researchers emphasize the need for caution when prescribing this medication, especially for first-time users.